Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.
Chitnis T, Qureshi F, Gehman VM, Becich M, Bove R, Cree BAC, Gomez R, Hauser SL, Henry RG, Katrib A, Lokhande H, Paul A, Caillier SJ, Santaniello A, Sattarnezhad N, Saxena S, Weiner H, Yano H, Baranzini SE. Chitnis T, et al. Among authors: lokhande h. Nat Commun. 2024 May 20;15(1):4297. doi: 10.1038/s41467-024-48602-9. Nat Commun. 2024. PMID: 38769309 Free PMC article.
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis.
Chitnis T, Qureshi F, Gehman VM, Becich M, Bove R, Cree BAC, Gomez R, Hauser SL, Henry RG, Katrib A, Lokhande H, Paul A, Caillier SJ, Santaniello A, Sattarnezhad N, Saxena S, Weiner H, Yano H, Baranzini SE. Chitnis T, et al. Among authors: lokhande h. medRxiv [Preprint]. 2023 Jul 3:2023.06.28.23291157. doi: 10.1101/2023.06.28.23291157. medRxiv. 2023. Update in: Nat Commun. 2024 May 20;15(1):4297. doi: 10.1038/s41467-024-48602-9 PMID: 37461671 Free PMC article. Updated. Preprint.
Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis.
Chitnis T, Foley J, Ionete C, El Ayoubi NK, Saxena S, Gaitan-Walsh P, Lokhande H, Paul A, Saleh F, Weiner H, Qureshi F, Becich MJ, da Costa FR, Gehman VM, Zhang F, Keshavan A, Jalaleddini K, Ghoreyshi A, Khoury SJ. Chitnis T, et al. Among authors: lokhande h. Clin Immunol. 2023 Aug;253:109688. doi: 10.1016/j.clim.2023.109688. Epub 2023 Jul 4. Clin Immunol. 2023. PMID: 37414379 Free article.
Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.
Bose G, Healy BC, Saxena S, Saleh F, Paul A, Barro C, Lokhande HA, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttmann CRG, Bakshi R, Weiner HL, Chitnis T. Bose G, et al. Among authors: lokhande ha. Mult Scler Relat Disord. 2023 Jun;74:104695. doi: 10.1016/j.msard.2023.104695. Epub 2023 Apr 2. Mult Scler Relat Disord. 2023. PMID: 37060852
Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects.
Chitnis T, Kaskow BJ, Case J, Hanus K, Li Z, Varghese JF, Healy BC, Gauthier C, Saraceno TJ, Saxena S, Lokhande H, Moreira TG, Zurawski J, Roditi RE, Bergmark RW, Giovannoni F, Torti MF, Li Z, Quintana F, Clementi WA, Shailubhai K, Weiner HL, Baecher-Allan CM. Chitnis T, et al. Among authors: lokhande h. Front Immunol. 2022 Nov 23;13:956907. doi: 10.3389/fimmu.2022.956907. eCollection 2022. Front Immunol. 2022. PMID: 36505477 Free PMC article.
21 results